
32.13 Delayed Data As of May 30 | ![]() Today’s Change | 25.07 Today|||52-Week Range 34.47 | +3.65% Year-to-Date |
SECTOR Health Technology | INDUSTRY Pharmaceuticals: Major | MARKET CAP $51.1B |
Takeda Pharmaceutical Co., Ltd. 4-1-1 Dosho-machi Osaka Osaka 540-8645 |
Christophe Weber | President, CEO & Representative Director |
Constantine Saroukos | Chief Financial Officer & Director |
Andrew S. Plump | Director, President-Research & Development |
Michael E. Mendelsohn | Chief Medical & Scientific Officer |
Norimasa Takeda | Chief Accounting Officer & Corporate Controller |